Miracle Mile Advisors LLC Acquires New Holdings in iShares Nasdaq Biotechnology ETF (IBB)

Share on StockTwits

Miracle Mile Advisors LLC acquired a new position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 1,790 shares of the financial services provider’s stock, valued at approximately $200,000.

Other large investors have also recently made changes to their positions in the company. Stone House Investment Management LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF during the first quarter worth $27,000. Parkside Financial Bank & Trust acquired a new position in iShares Nasdaq Biotechnology ETF during the fourth quarter worth $29,000. Sontag Advisory LLC acquired a new position in iShares Nasdaq Biotechnology ETF during the fourth quarter worth $32,000. Trustcore Financial Services LLC acquired a new position in iShares Nasdaq Biotechnology ETF during the first quarter worth $34,000. Finally, Aspire Private Capital LLC acquired a new position in iShares Nasdaq Biotechnology ETF during the fourth quarter worth $40,000. Institutional investors and hedge funds own 67.92% of the company’s stock.

iShares Nasdaq Biotechnology ETF stock opened at $103.77 on Monday. iShares Nasdaq Biotechnology ETF has a one year low of $89.01 and a one year high of $122.97.

ILLEGAL ACTIVITY NOTICE: “Miracle Mile Advisors LLC Acquires New Holdings in iShares Nasdaq Biotechnology ETF (IBB)” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/4347285/miracle-mile-advisors-llc-acquires-new-holdings-in-ishares-nasdaq-biotechnology-etf-ibb.html.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Story: What is Depreciation?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Twilio  Upgraded by TheStreet to C
Twilio Upgraded by TheStreet to C
HV Bancorp  Downgraded by TheStreet to C+
HV Bancorp Downgraded by TheStreet to C+
Velocity Composites  Posts Quarterly  Earnings Results
Velocity Composites Posts Quarterly Earnings Results
Traders Purchase High Volume of Call Options on Pyxus International
Traders Purchase High Volume of Call Options on Pyxus International
SUN ART RETAIL/ADR  Shares Up 3.2%
SUN ART RETAIL/ADR Shares Up 3.2%
Contango Income Generator  Trading Up 0.7%
Contango Income Generator Trading Up 0.7%


© 2006-2019 Ticker Report